487 The use of 18F-FDG to detect changes in atherosclerotic lesions in atherogenic apoE −/− mice
Lyne Sleiman, R.S. Beanlands, T. Stephanie, Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal), RA deKemp, M. Hasu, M. Thabet, Stewart C. Whitman, Jean‐Marc Renaud, G. W. Small, T. Dumochel
Cited by 0
Related Papers
The Use of <sup>18</sup>F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience
|Journal of Nuclear Medicine|2012|512
<sup>18</sup>F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to <sup>18</sup>F-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial
|Journal of Nuclear Medicine|2010|154
The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis
|Journal of Nuclear Cardiology|2013|87
Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging–Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease
|Circulation Cardiovascular Imaging|2016|86
The Effects of Continuous Positive Airway Pressure on Myocardial Energetics in Patients With Heart Failure and Obstructive Sleep Apnea
|Journal of the American College of Cardiology|2007|75